Treatment of Pulmonary Arterial Hypertension with Leukotriene Inhibitors

• 收藏
• 分享

专利权人:

发明人:

Mark R. Nicolls,Wen Tian,Jayakumar Rajadas

申请号：

US14954789

公开号：

US20160193168A1

申请日:

2015.11.30

申请国别(地区):

US

年份:

2016

代理人:

摘要：

Pulmonary arterial hypertension (PAH) can be prevented in persons susceptible to the diseases and PAH patients can be treated by administering an effective dose of a leukotriene inhibitor. Suitable inhibitors include leukotriene A4 hydrolase (LTA4H) inhibitors, leukotriene B4 receptor (BLT1/BLT2) antagonists, 5-lipoxygenase (5-LO) inhibitors, and 5-lipoxgygenase activating protein (FLAP) inhibitors.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/